← Back to Clinical Trials
Recruiting EARLY_Phase 1 NCT05486637

Vocal Emotion Communication With Cochlear Implants

◆ AI Clinical Summary
Plain-language summary for patients

Trial Parameters

Condition Cochlear Hearing Loss
Sponsor Father Flanagan's Boys' Home
Study Type INTERVENTIONAL
Phase EARLY_Phase 1
Enrollment 255
Sex ALL
Min Age 6 Years
Max Age 80 Years
Start Date 2022-07-01
Completion 2027-06-30
Interventions
Perception of acoustic cues to emotionProduction of acoustic cues to emotion

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

Patients with hearing loss who use cochlear implants (CIs) show significant deficits and strong unexplained intersubject variability in their perception and production of spoken emotions in speech. This project will investigate the hypothesis that "cue-weighting", or how patients utilize the different acoustic cues to emotion, accounts for significant variance in emotional communication with CIs. The results will focus on children with CIs, but parallel measures in postlingually deaf adults with CIs will be made, ensuring that results of these studies benefit social communication by CI patients across the lifespan by informing the development of technological innovations and improved clinical protocols.

Eligibility Criteria

Inclusion Criteria: * Prelingually deaf children with cochlear implants * Postlingually deaf adults with cochlear implants * Normally hearing children * Normally hearing adults Exclusion Criteria: * Non-native speakers of American English * Prelingually deaf individuals who receive cochlear implants after age 12 * Adults unable to pass a basic cognitive screen

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology
}